Search results for "MESH: Toxoplasma"

showing 2 items of 2 documents

Characterization and multicentric validation of a common standard for Toxoplasma gondii detection using nucleic acid amplification assays.

2014

ABSTRACT The molecular diagnosis of toxoplasmosis essentially relies upon laboratory-developed methods and suffers from lack of standardization, hence the large diversity of performances between laboratories. Moreover, quantifications of parasitic loads differ among centers, a fact which prevents the possible prediction of the severity of this disease as a function of parasitic loads. The objectives of this multicentric study performed in eight proficient laboratories of the Molecular Biology Pole of the French National Reference Center for Toxoplasmosis (NRC-T) were (i) to assess the suitability of a lyophilized preparation of Toxoplasma gondii as a common standard for use in this PCR-base…

Microbiology (medical)MESH: Reference Standards*MESH: Molecular Diagnostic Techniques/methods*MESH: Parasite Load/standards[SDV]Life Sciences [q-bio]Toxoplasma gondiidiagnosticParasitic loadsParasite LoadMESH: Nucleic Acid Amplification Techniques/standards*MESH: Toxoplasma/isolation & purification*medicineMolecular diagnostic techniquesHumansNational levelReference standardsMESH: Parasite Load/methodsstandardizationMESH: HumansbiologyMESH: Nucleic Acid Amplification Techniques/methods*Toxoplasma gondiiNucleic acid amplification techniqueMESH: Toxoplasmosis/diagnosis*MESH: Molecular Diagnostic Techniques/standards*Reference Standardsbiology.organism_classificationmedicine.diseaseVirologyToxoplasmosisquantification3. Good healthMESH: FranceMolecular Diagnostic TechniquesImmunologyNucleic acidMESH: Toxoplasma/geneticsParasitologyFranceNucleic Acid Amplification TechniquesToxoplasmaToxoplasmosisJournal of clinical microbiology
researchProduct

Molecular Diagnosis of Toxoplasmosis in Immunocompromised Patients: a 3-Year Multicenter Retrospective Study

2015

ABSTRACT Toxoplasmosis is a life-threatening infection in immunocompromised patients (ICPs). The definitive diagnosis relies on parasite DNA detection, but little is known about the incidence and burden of disease in HIV-negative patients. A 3-year retrospective study was conducted in 15 reference laboratories from the network of the French National Reference Center for Toxoplasmosis, in order to record the frequency of Toxoplasma gondii DNA detection in ICPs and to review the molecular methods used for diagnosis and the prevention measures implemented in transplant patients. During the study period, of 31,640 PCRs performed on samples from ICPs, 610 were positive (323 patients). Blood ( n …

Microbiology (medical)Microbiological Techniquesmedicine.medical_specialtyMESH: Molecular Diagnostic TechniquesAsymptomaticPolymerase Chain Reactionlaw.inventionImmunocompromised Host[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseaseslawInternal medicinemedicineMESH: Immunocompromised HostPrevalenceHumansComputingMilieux_MISCELLANEOUSPolymerase chain reactionImmunodeficiencySurvival analysisMESH: PrevalenceRetrospective Studies[SDV.EE.SANT]Life Sciences [q-bio]/Ecology environment/HealthMESH: Humansbusiness.industryIncidence (epidemiology)MESH: ToxoplasmaMESH: Microbiological TechniquesRetrospective cohort studyMESH: Polymerase Chain ReactionMESH: Retrospective Studiesmedicine.diseaseSurvival AnalysisToxoplasmosis3. Good healthSurgeryMESH: France[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyMolecular Diagnostic TechniquesMESH: Survival AnalysisChemoprophylaxisMESH: ToxoplasmosisParasitologyFrancemedicine.symptombusinessToxoplasmaToxoplasmosis
researchProduct